Papers
4
Total Citations
133
H-Index
3
About
Dr. Mae-Yen Tan is a leading urologic surgeon and researcher whose work has fundamentally reshaped the perioperative management of bladder cancer patients. Her primary research focus is on optimizing outcomes for patients undergoing radical cystectomy, particularly through the integration of robot-assisted surgery and enhanced recovery after surgery (ERAS) protocols. Her landmark 2017 study, cited 76 times, demonstrated that combining intracorporeal robot-assisted radical cystectomy (iRARC) with an ERAS pathway significantly reduces hospital length of stay and improves postoperative outcomes compared to traditional open surgery—a concept she describes as "aggregating marginal gains." Dr. Tan has also provided critical insights into the complications associated with iRARC, including a detailed analysis of postoperative complications (36 citations) and the crucial finding that blood transfusion requirements, rather than preoperative anemia, are the primary driver of perioperative complications (19 citations). Her work has helped establish iRARC as a safer, more efficient standard of care, directly influencing surgical practice and patient recovery pathways worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4